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OBJECTIVE—Stress stimuli such as tumor necrosis factor
(TNF) have been shown to induce insulin receptor substrate
(IRS)-1 serine phosphorylation and insulin resistance by trans-
activation of ErbB receptors. We aimed at elucidating the
potential role of p38 mitogen-activated protein kinase (p38MAPK)
in mediating stress-induced ErbB receptors activation.
RESEARCH DESIGN AND METHODS—p38MAPK effect on
ErbBs transactivation and insulin signaling was assessed in Fao
or HepG2 cells, exposed to stress stimuli, and on metabolic
parameters in ob/ob and C57/BL6 mice.
RESULTS—High-fat diet–fed mice and ob/ob mice exhibited
elevated hepatic p38MAPK activation associated with glucose
intolerance and hyperinsulinemia. Liver expression of dominant-
negative (DN)-p38MAPKa in ob/ob mice reduced fasting insulin
levels and improved glucose tolerance, whereas C57/BL6 mice
overexpressing wild-type p38MAPKa exhibited enhanced IRS-1
serine phosphorylation and reduced insulin-stimulated IRS-1 ty-
rosine phosphorylation. Fao or HepG2 cells exposed to TNF,
anisomycin, or sphingomyelinase demonstrated rapid transacti-
vation of ErbB receptors leading to PI3-kinase/Akt activation
and IRS-1 serine phosphorylation. p38MAPK inhibition either by
SB203580, by small interfering RNA, or by DN-p38MAPKa de-
creased ErbB receptors transactivation and IRS-1 serine phosphor-
ylation and partially restored insulin-stimulated IRS-1 tyrosine
phosphorylation. When cells were incubated with speciﬁc ErbB
receptors antagonists or in cells lacking ErbB receptors, aniso-
mycin- and TNF-induced IRS-1 serine phosphorylation was atten-
uated, despite intact p38MAPK activation. The stress-induced
p38MAPK activation leading to ErbB receptors transactivation
was associated with intracellular reactive oxygen species gener-
ation and was attenuated by treatment with antioxidants.
CONCLUSIONS—Hepatic p38MAPK is activated following var-
ious stress stimuli. This event is upstream to ErbB receptors
transactivation and plays an important role in stress-induced IRS-1
serine phosphorylation and insulin resistance. Diabetes 60:1134–
1145, 2011
I
nsulin resistance has been strongly associated with
obesity (1) and a variety of pathological stress con-
ditions, including inﬂammatory diseases, hemorrhage,
thermal injury, sepsis, and cancer cachexia (2–5).
These pathological states are characterized by increased in-
ﬂammatory response as indicated by high levels of proin-
ﬂammatory cytokines, such as tumor necrosis factor (TNF)-a
(6–8). Numerous studies have demonstrated the central role
of TNF in obesity-induced insulin resistance by promoting
Ser phosphorylation of insulin receptor (IR) substrate (IRS)-
1, which impairs IR-IRS-1 interaction compromising insulin
signal propagation (9–11). These cellular effects of TNF had
been suggested to be mediated by the sphingomyelin path-
way as evident by the effects of sphingomyelinase (SMase)
and cell-permeable ceramide analogs (11,12).
Increased IRS-1 Ser phosphorylation and impaired meta-
bolic responses to acute insulin stimulation in cellular
systems representing liver, skeletal muscle, and adipose
tissues were demonstrated not only in response to TNF
but also as a consequence of additional stress stimuli, such
as oxidative conditions (13,14), osmotic shock, and the
translation inhibitor anisomycin (AN) (15–17). However,
the downstream pathways linking between the various
stress-stimuli and increased IRS-1 Ser phosphorylation are
not fully elucidated. The activation of p38 mitogen-activated
protein kinase (p38MAPK) has been suggested as one po-
tential candidate for mediating IRS-1 Ser phosphorylation
by cellular stresses, although not directly, mainly by in vitro
studies demonstrating improvement of stress-induced in-
sulin resistance with pharmacological p38MAPK inhibitors
(18–20).
Previously, we have demonstrated that stress stimuli
such as TNF and AN promote ligand-independent trans-
activation of ErbB2 and ErbB3 receptors (members of the
epidermal growth factor [EGF]/ErbB family of receptor
Tyr-kinases), resulting in their association with the p85-
subunit of PI3-kinase (PI3K) and augmented PI3K activity.
Stimulation of the PI3K signal cascade, downstream to
ErbB receptors, induced Ser phosphorylation of IRS pro-
teins and promoted insulin resistance (16). Since p38MAPK
activation, a central component of the stress response (21),
was demonstrated to be linked to the ErbB family activity
in several cellular models (22,23), we aimed at assessing the
potential role of p38MAPK activation in ErbB receptors
mediated hepatic insulin resistance.
In the current study we provide evidence in various
models that stress-induced activation of p38MAPKa in the
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ORIGINAL ARTICLEliver is an upstream event, crucial for transactivation of the
ErbB receptors leading to IRS-1 Ser phosphorylation and
desensitization of insulin signaling.
RESEARCH DESIGN AND METHODS
Cell culture studies. Rat hepatoma Fao and human hepatoma HepG2 cells
were grown in RPMI-1640 and Dulbecco’s modiﬁed Eagle’s medium (DMEM),
respectively, supplemented with 10% FCS. Conﬂuent monolayers, deprived of
serum for 16 h, were incubated without or with SMase (neutral, Staphylo-
coccus aureus), TNF, or AN at the indicated concentrations and time intervals
and then stimulated for the indicated times without or with 100 nmol/L insulin.
In glucose oxidase (GO; Sigma) experiments, GO was added to serum-free
RPMI-1640 medium for 10 min at 37°C to generate H2O2 and then added to
cells at the indicated concentrations and time intervals. In some experiments,
cells were treated without or with different signaling inhibitors (LY294002,
PD168393, SB203580, PD98059, AG825 [Calbiochem]) for 30 min or with var-
ious antioxidants (N-acetyl-L-cysteine [NAC], glutathione [GSH], diphenylene-
iodoniumchloride [DPI] [Sigma]) for 1 h at the indicated concentrations before
incubation without or with stress stimuli and insulin. Cells were solubilized at
4°C with buffer A (Supplementary Data). After three freeze-thaw cycles, cell
extracts were centrifuged (12,000g, 30 min, 4°C) and supernatants were col-
lected as the cytosolic fraction. Resulting pellets were solubilized with buffer B
(Supplementary Data) and supernatants (12,000g, 15 min, 4°C) were collected
as the particulate fraction. Total cell extracts were prepared by solubilizing cells
with buffer B. Following separation by SDS-PAGE, proteins were subjected to
Western immunoblotting with antibodies directed against IR, IRS-1 (16), ErbB2-
phospho-(p)Tyr
1248,I R S - 1 - p S e r
307, p85-PI3K (Upstate Biotechnology), pTyr
(Transduction Laboratories), ErbB3-pTyr
1289,A k t - p S e r
473,I R S - 1 - p S e r
612,I R S - 1 -
pSer
636/639, MAPKAPK2-pThr
334 (Cell Signaling Technology), p38MAPK-Thr
180/
Tyr
182, a-tubulin, MKK-3/6-pSer
189/207, MKK-3 (Sigma), ErbB1, ErbB2, ErbB3,
p38MAPK (Santa Cruz Biotechnology), ErbB1-pTyr
1086, ErbB1-pTyr
1173,a n d
IRS-1-pTyr
612 (Biosource). Ser
307,S e r
612,S e r
632,a n dT y r
608 in rat IRS-1 are
equivalent to Ser
312,S e r
616,S e r
636, and Tyr
612 in human IRS-1, respectively.
Adenoviruses. The DN-p38MAPKa (Ad.p38/AF, the AF mutant cannot be
phosphorylated, since the TGY dual phosphorylation site has been changed to
AGF) and wild-type (WT)-p38MAPKa adenoviruses, constructed as described
(24), were provided by Dr. Jiahuai Han. b-Galactosidase (b-gal) adenovirus,
used as control in all experiments, was obtained from Cell Biolabs. Viral titters
were determined by QuickTiter adenovirus titer immunoassay kit (Cell Biolabs).
Cells infection with adenoviral constructs. Cells were infected with ade-
noviruses at multiplicity of infection (MOI) as indicated, and experiments were
performed 48 h after infection. Infection efﬁciency was 70–80% as determined
by green ﬂuorescent protein (GFP)-adenovirus.
Gene silencing. Fao or HepG2 cells were transfected by 100 nmol/L rat
p38MAPKa or human ErbB1 SMARTpool small interfering RNAs (siRNAs)
(Dharmacon). Nontargeted siRNA was used as control. Experiments were
performed 96 h after transfection.
Growing Fao cells at various cell densities. Conﬂuent Fao cells, grown in
90-mm plates, were divided into three (cell density-1) or forty-eight (cell
density-1/16) 60-cm plates. After 48 h, cells were treated with 50 ng/mL AN for
30 min and assayed as indicated above.
Immunoprecipitation. Cell extracts were incubated (2–12 h, 4°C) with the
indicated antibodies. ErbB2/ErbB3 heterodimer immunoprecipitation was
performed by using a mixture of anti-ErbB2 (2 mg) and anti-ErbB3 antibodies
(2 mg). Immunocomplexes were incubated (1 h, 4°C) with protein G/A-
Sepharose beads mixture, collected, washed three times with buffer B, and
subjected to SDS-PAGE following immunoblotting with the indicated anti-
bodies.
IRS-1 binding to immobilized IR. IR was puriﬁed from Fao cells on a wheat-
germ agglutinin (WGA) coupled to agarose (16). Immobilized IR was incubated
(2 h, 4°C) with cytosolic extracts derived from Fao cells treated with AN or
SMase. IR-IRS-1 binding was determined as previously described (16).
PI3K assay. Total extracts were immunoprecipitated using p85-PI3K or
mixtureofErbB2/ErbB3antibodies.PI3Kactivityintheimmunocomplexeswas
determined as previously described (16).
Reactive oxygen species production. Cells, washed twice in RPMI-1640
medium without phenol red, were incubated at 37°C in medium containing
5 mM of reactive oxygen species (ROS) sensitive ﬂuorescent dye, dichloro-
ﬂuorescein (CM-DCF). After 1 h, cells were washed with PBS and ﬂuorescence
was immediately measured in a plate reader (Tecan) with an excitation/emission
wavelength of 485/515 nm.
Animal studies. C57/BL6 male mice 8 or 10 weeks old and 8-week-old ob/ob
male mice (Harlan Laboratories) were maintained on a 12-h light/dark cycle.
All protocols for animal uses were reviewed and approved by the Animal Care
Committee of the Sheba Medical Center and were in accordance with In-
stitutional Animal Care and Use Committee guidelines.
DN-p38MAPKa, WT-p38MAPKa, and b-gal (control for viral infection)
adenoviruses were injected into mice through the tail vein (200 mLo f1 –30 3
10
10 ifu/mL, diluted in PBS). Noteworthy, systemic glucose homeostasis and
hepatic IR, IRS-1, and Akt protein levels were not signiﬁcantly different in
b-gal-infected mice compared with noninfected mice (Supplementary Fig. 1),
unlike recent ﬁndings in rats (25). Quantitative real-time PCR (qPCR) analysis
(Supplementary Data) exhibited a speciﬁc expression of p38MAPK, delivered
by the adenoviruses, in the liver but not in skeletal muscle. Intraperitoneal
glucose tolerance tests (IPGTT) were performed 5 days after adenovirus in-
jection by using 2 g glucose/kg of body weight after a 6- or 12-h fast. Blood
glucose values were determined with a glucose-meter (Bayer). Plasma aliquots
were obtained 1 day post GTT and after 6- or 12-h fasting, as indicated, and
stored at 220°C. Insulin levels were determined by ultra-sensitive mouse in-
sulin ELISA kit (Mercodia).
Insulin signaling in vivo. Insulin signaling in vivo was performed by injecting
2 mU insulin/g body weight in the portal vein of anesthetized animals. Animals
were killed 5 min later, and the liver was harvested, frozen in liquid nitrogen,
and stored at 280°C before further analysis.
Tissue extraction. Liver tissues from adenoviral-infected mice harvested
6 days after adenovirus injection and from high-fat diet–fed mice (HFD; 42% kcal
from fat for 20 weeks or 60% kcal from fat for 8 weeks) were homogenized in
Buffer B. Protein extracts were used for immunoblotting as described above.
Statistical analysis. All data are expressed as mean 6 SE. Two-tailed Student
t tests were performed on data at a minimum P , 0.05 threshold.
RESULTS
p38MAPKa mediates insulin resistance in vivo. In
agreement with previous observations (26,27), both ob/ob
mice as well as C57/BL6 mice fed with HFD demonstrated
elevated liver p38MAPK activity (two- to threefold), com-
pared with lean C57/BL6 mice, as indicated by its in-
creased phosphorylation (Fig. 1A). To assess the role of
p38MAPK in mediating hepatic insulin resistance in these
models, we over-expressed DN-p38MAPKa or b-gal, a con-
trol adenovirus, in the liver of ob/ob mice by tail vein in-
jection of adenoviral-based expression vectors (Fig. 1B–E
and Supplementary Fig. 2, representing two independent
experiments). Overexpression of DN-p38MAPKa resulted
in a signiﬁcant decrease in hepatic p38MAPK activation
(1.7-fold, Fig. 1B, and 1.9-fold, Supplementary Fig. 2A),
measured at day 6 post adenovirus administration. The
difference in p38MAPK activity among the DN-p38MAPKa
and the b-gal injected mice closely resembled differences
observed in p38MAPK activation between obese and lean
mice.
GTT, performed 5 days after adenovirus administration,
revealed a signiﬁcant improvement in glucose tolerance in
mice overexpressing DN-p38MAPKa (Fig. 1C, Supple-
mentary Fig. 2C). In addition, fasting insulin levels were
considerably lower in the DN-p38MAPKa expressing mice
compared with b-gal controls (Fig. 1D), indicating im-
proved insulin sensitivity. qPCR analysis revealed that
DN-p38MAPKa overexpression in the liver resulted in
a signiﬁcant downregulation of phosphoenolpyruvate car-
boxykinase (PEPCK), one of the key enzymes involved in
gluconeogenesis (Fig. 1E, Supplementary Fig. 2D).
To further support the importance of liver p38MAPK
in mediating insulin resistance, lean C57/BL6 mice were
injected via the tail vein with adenoviruses that express
WT-p38MAPKa or b-gal. As demonstrated in Fig. 2A,
mice overexpressing WT-p38MAPKa exhibited increased
p38MAPK activation in the liver, accompanied by increased
phosphorylation of IRS-1 on Ser612 and Ser632 residues
(Fig. 2B). Signaling studies performed after acute in-
jection of either saline or insulin for 5 min revealed that
WT-p38MAPKa overexpression in liver reduced insulin
ability to stimulate both Tyr phosphorylation of IRS-1
(Tyr
608) and Akt activation (Fig. 2C) .A ss h o w ni nF i g .2 D,
there was no signiﬁcant difference in glucose tolerance
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Nevertheless, fasting insulin levels were signiﬁcantly
higher in WT-p38MAPKa expressing mice compared with
b-gal controls (Fig. 2E), indicating that p38MAPKa over-
expression increases insulin resistance. Expression levels
of PEPCK were increased (45%) by WT-p38MAPKa treat-
ment compared with b-gal controls, although this differ-
ence did not reach statistical signiﬁcance (P = 0.25).
Similar ﬁndings were reported in mice overexpressing WT-
Jun NH2-terminal kinase (JNK) in the liver (28).
p38MAPK mediates stress-induced IRS-1 Ser phos-
phorylation leading to insulin signal desensitization.
To further test the potential role of p38MAPK in the de-
velopment of hepatic insulin resistance, we evaluated the
effect of promoting or suppressing p38MAPK activity on
IRS-1 Ser phosphorylation and insulin signal transduction
in vitro. For these studies we used human HepG2 (Fig. 3A–C)
and rat Fao (Fig. 3D–G) hepatoma cells treated with
known inducers of insulin resistance such as TNF, SMase,
or AN (11,16). The efﬁcacy of the various methodologies
used to manipulate p38MAPK activity was conﬁrmed by
evaluating the phosphorylation of p38MAPK or its down-
stream substrate MAPKAPK2.
Incubation of HepG2 cells with TNF increased p38MAPK
activation and IRS-1 Ser phosphorylation as demonstrated
for Ser
636/9 and Ser
312 (Fig. 3A), accompanied by decreased
ability of insulin to promote IRS-1 Tyr phosphorylation
(Fig. 3B). Overexpression of WT-p38MAPKa enhanced
TNF effect on IRS-1 Ser phosphorylation (Fig. 3A), lead-
ing to further deterioration in insulin signaling (Fig. 3B),
whereas inhibiting p38MAPKa activation by DN-p38MAPKa
adenovirus infection (Fig. 3A and B) or pharmacologically
by SB203580 (Fig. 3C) attenuated TNF effects.
Similar to our observations in HepG2, incubation of Fao
cells with AN or SMase increased IRS-1 phosphorylation
on Ser
632,S e r
612, and Ser
307 (Fig. 3D–F). Inhibition of stress-
induced p38MAPK activation, either by DN-p38MAPKa
overexpression (Fig. 3D), by knockdown of p38MAPKa
expression with speciﬁc siRNA sequences (Fig. 3E), or by
SB203580 (Fig. 3F)r e s u l t e di ns i g n i ﬁcant reduction in IRS-1
phosphorylation on these residues. As expected, IRS-1 Ser
phosphorylation, induced by either AN or SMase, led to
decreased ability of insulin to promote IRS-1 Tyr phos-
phorylation (Fig. 3G, upper panels), because of impaired
interaction of Ser phosphorylated IRS-1 with the IR (Fig. 3G,
lower panel), as assessed by in vitro interaction assay (16).
FIG. 1. Effects of adenoviral DN-p38MAPKa overexpression in the liver, on insulin resistance, and glucose intolerance in obese mice models.
A: The levels of hepatic p38MAPKa (p38), p-p38MAPK (p-p38), and a-tubulin were assessed in C57/BL6 (C57) mice fed with standard diet or HFD
and in ob/ob mice, using Western blot analysis. Quantiﬁcation of p-p38 and p38 immunoblots was performed using ImageJ analysis. Results are
expressed as p-p38 relative to p38 in control (n = 5) and HFD (n = 5) mice or in control (n = 3) and ob/ob (n = 3) mice and are presented as the
means 6 SE. B: ob/ob mice were injected with b-gal (n = 6) or DN-p38a (n = 6) adenoviral constructs via tail vein. Levels of p38a, p-p38, or
a-tubulin in the liver were assessed using Western blot analysis. Quantiﬁcation of immunoblots was performed using ImageJ analysis. The results
are expressed as p-p38 or p38 relative to the loading control (a-tubulin) and are presented as the means 6 SE. C: IPGTT was performed 5 days
after adenovirus injection, after a 6-h fast. The area under the curve (AUC) was estimated by summing the numerical integration values of suc-
cessive linear segments of the glucose curve for 0–15, 15–30, 30–60, 60–90 and 90–120 min. D: Blood insulin levels were measured after 6-h fasting.
E: PEPCK1 mRNA expression was assessed by qPCR.
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both IR-IRS-1 interaction and the subsequent Tyr phos-
phorylation of IRS-1 (Fig. 3G).
p38MAPK activation mediates stress-induced ErbB
receptors transactivation. Previously we have demon-
strated the importance of ErbB receptors transactivation
in stress-induced insulin resistance. Our ﬁndings revealed
that activation of a PI3K cascade, downstream to ErbB
receptors by cellular stressors, induces Ser phosphoryla-
tion of IRS proteins culminating in insulin signaling de-
sensitization (16).
To assess the role of p38MAPK in mediating insulin re-
sistance in an ErbB-dependent manner, we evaluated the
effect of inhibiting or augmenting p38MAPK activity on
ErbB receptors activation in both Fao (Fig. 4) and HepG2
(Fig. 5A–C) cells. In accordance with our previous ﬁndings,
Tyr phosphorylation of ErbB2 and ErbB3, the predominant
ErbB receptors in Fao cells (16), could be detected fol-
lowing 5- to 10-min incubation with AN or SMase (Fig. 4A,
upper panels). Stress-induced p38MAPK activation fol-
lowed a similar time course (Fig. 4A, lower panels). As
depicted in Fig. 4B, silencing of p38MAPKa suppressed
AN-induced ErbB2/ErbB3 Tyr phosphorylation, as dem-
onstrated for ErbB2-Tyr
1248, one of the major ErbB2
autophosphorylation sites, and ErbB3-Tyr
1289, one of the
six ErbB3 binding sites for the p85-subunit of PI3K. Simi-
larly, inhibition of p38MAPK activation, induced by the
various stress stimuli, using either DN-p38MAPKa over-
expression (Fig. 4C) or SB203580 (Fig. 4D and Supple-
mentary Fig. 3A), effectively reduced ErbB2/ErbB3 total
Tyr phosphorylation, as well as ErbB2 phosphorylation on
Tyr
1248. Moreover, parallel to the efﬁcient reduction in AN-
induced ErbB2/ErbB3 Tyr phosphorylation by SB203580,
a signiﬁcant reduction in ErbB2/ErbB3-associated PI3K
FIG. 2. Effects of adenoviral p38MAPKa overexpression in the liver, on insulin signaling, and glucose tolerance in C57/BL6 mice. A: C57 male mice
were infected with b-gal (n = 15) or WT-p38a (n = 15) adenoviral constructs via tail vein injection. The levels of p38a, p-p38, and a-tubulin in the
liver were assessed using Western blot analysis. Quantiﬁcation of immunoblots was performed using ImageJ analysis. The results are expressed as
p-p38 or p38 relative to the loading control (a-tubulin) and are presented as the means 6 SE. B: Levels of IRS-1-pSer
632, IRS-1-pSer
612, and IRS-1
in the liver were determined by immunoblotting with speciﬁc antibodies as indicated. Quantiﬁcation of immunoblots was performed using ImageJ
analysis. The results are expressed as IRS-1-pSer
632, IRS-1-pSer
612, relative to IRS-1, and are presented as the means 6 SE. C: Mice infected with
b-gal (n = 5) or with WT-p38a (n = 5) adenoviral constructs were treated with insulin as described in RESEARCH DESIGN AND METHODS. Insulin-induced
Tyr phosphorylation of IRS-1 and Akt activation was analyzed by antibodies against IRS-1-pTyr
608, IRS-1, Akt-pSer
473, and Akt. Quantiﬁcation of
immunoblots was performed using ImageJ analysis. The results are expressed as IRS-1-pTyr
608 relative to IRS-1 and Akt-pSer
473 relative to Akt
and are presented as the means 6 SE. D: IPGTT was performed 5 days after adenovirus injection, after 12-h fasting. The AUC was estimated as
described in Fig. 1C. E: Blood glucose and insulin levels were measured after 12-h fasting.
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473 phosphorylation was observed
(Fig. 4E).
We next evaluated the involvement of p38MAPK in
stress-induced ErbB receptors transactivation in HepG2
cells. TNF promoted Tyr phosphorylation of ErbB1, the
predominant ErbB receptor in these cells, as demonstrated
by its increased phosphorylation on Tyr
1173 and Tyr
1086
residues (Fig. 5A), as well as Tyr phosphorylation of ErbB3,
as demonstrated for Tyr
1289 (Fig. 5B). This enhanced
phosphorylation was accompanied by ErbB1 and ErbB3
association with the p85-subunit of PI3K (data not shown).
The transactivation of ErbB1 and ErbB3 by TNF was sig-
niﬁcantly augmented with overexpression of WT-p38MAPKa
but attenuated in cells overexpressing DN-p38MAPKa (Fig.
5A) or by SB203580 (Fig. 5B). Moreover, p38MAPK inhibi-
tion by SB203580 resulted in a signiﬁcant reduction in TNF-
induced Akt-Ser
473 phosphorylation (Fig. 5C). Noteworthy,
whereas stress-induced ErbB receptors Tyr phosphorylation
was attenuated by p38MAPK inhibition, their phosphoryla-
tion, stimulated by NDF-b1, an ErbB3 ligand, or by EGF, an
ErbB1 ligand, was unaffected by SB203580 (Supplementary
Fig. 3B). These results conﬁrm that p38MAPK serves as an
upstream mediator of stress-induced ErbB receptors trans-
activation.
When assessed in vivo, C57/BL6 mice, in which ErbB1
is the predominant ErbB in liver, exhibited signiﬁcant
FIG. 3. p38MAPK mediates stress-induced IRS-1 Ser phosphorylation leading to insulin signal desensitization. HepG2 cell experiments: A: Cells
infected with 15 MOI (ifu/cell) of b-gal, DN-p38a, and WT-p38a adenoviral constructs for 48 h were treated without or with 5 nmol/L TNF for 30
min. Total cell extract proteins were resolved by SDS-PAGE and then immunoblotted with antibodies as indicated. B: Cells infected as in A were
treated without or with 5 nmol/L TNF for 30 min and then incubated without or with 100 nmol/L insulin for 5 min. Total cell extracts proteins were
analyzed by immunoblot analysis using anti-IRS-1-pTyr
612 antibodies. C: Cells were treated without or with 10 mmol/L SB203580 (SB) for 30 min,
before incubation with 5 nmol/L TNF for 30 min. Total cell extract proteins were analyzed by immunoblot analysis using anti-IRS-1-pSer
636/9, anti-
IRS-1, and anti-MAPKAPK2-pThr
334 antibodies. Fao cell experiments: D and E: Cells infected DN-p38a adenoviral constructs at the indicated MOI
(ifu/cell) for 48 h (D), or transfected by p38a or nontargeted (N.T) siRNA for 96 h (E), were treated without or with 50 ng/mL AN for 30 min. IRS-
1-pSer
632, IRS-1, p-p38, and p38 in total cell extract proteins were examined with immunoblot analysis using the indicated antibodies. F: Cells were
treated without or with 10 mmol/L SB203580 for 30 min, before incubation without or with 300 mU/mL SMase or 50 ng/mL AN for 30 min at 37°C.
Total cell extract proteins were resolved by SDS-PAGE, and then immunoblotted with antibodies as indicated. G: Protein extracts from Fao cells
treated as described above were incubated without or with 100 nmol/L insulin for 1 min. Proteins from cell lysates were immunoprecipitated with
anti-IRS-1 antibodies, resolved by SDS-PAGE, and immunoblotted with anti-pTyr antibodies (G, upper left panel) or directly resolved by SDS-
PAGE and then immunoblotted with IRS-1-pTyr
608 antibodies (G, upper right panel). Cytosolic proteins from cells treated without or with
SB203580 before incubation without or with AN as described above were bound to immobilized IR. IR-IRS complexes were subjected to immu-
noblot analysis with anti IRS-1 antibodies (G, lower panel). Each panel in A–G represents three to ﬁve independent experiments. In each panel,
the relative band intensity (RBI) of a given band presents the means of three to ﬁve independent experiments. Band intensity measurements were
performed using ImageJ analysis.
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p38MAPKa, as indicated by a twofold increase in its
Tyr
1173 phosphorylation (Fig. 5D). Furthermore, hepatic
expression of ErbB1 and ErbB3, as well as their Tyr
phosphorylation on ErbB1-Tyr
1173 and ErbB3-Tyr
1289, was
signiﬁcantly increased in C57/BL6 mice fed with HFD (Fig.
5E), in which elevated p38MAPK activity was demon-
strated (Fig. 1A). Taken together, our ﬁndings support the
notion that p38MAPK activation following stress stimuli is
an essential upstream event in transactivation of distinct
ErbB receptors, leading to impaired insulin action.
Incubation of Fao cells with insulin induces slow in-
crease (20–60 min) in IRS-1 Ser phosphorylation leading
to downmodulation of insulin receptor signaling (11). Be-
cause p38MAPK has been implicated in insulin signaling in
H4IIE hepatoma cells (29,30), we next evaluated whether
the p38MAPK-ErbB receptors pathway is activated by
insulin itself, as part of its negative feedback control.
Incubation of Fao cells with 100 nmol/L insulin for up to
60 min did not promote ErbB2/ErbB3 Tyr phosphoryla-
tion (Supplementary Fig. 4A). Additionally, in accordance
with prior studies (26,31,32), insulin, unlike stress stimuli,
had no signiﬁcant effect on p38MAPK phosphorylation in
Fao or HepG2 cells (Supplementary Fig. 4B and C). The
discrepancy in p38MAPK activation by insulin, reported
in the various liver cells (29–32), is unclear and may arise
from different expression of MAPK phosphatases or other
signals that attenuate p38MAPK activation by insulin (26).
Collectively, our ﬁndings support a role for p38MAPK-
ErbB pathway in the negative feedback control mecha-
nisms regulating hepatic insulin signaling under stress
conditions but not under physiological conditions.
ErbB receptors are essential for p38MAPK-mediated
IRS-1 Ser phosphorylation under stress conditions.
To ﬁrmly conﬁrm that ErbB receptors transactivation is
a necessary event in p38MAPK-mediated insulin resistance
FIG. 4. p38MAPK involvement in stress-induced ErbB2/ErbB3 transactivation in Fao cells. A: Cells were incubated with 300 mU/mL SMase or 50 ng/mL
AN for the indicated times at 37°C. Total cell proteins were analyzed by SDS-PAGE, and the blots were probed with anti-pTyr or anti-p-p38
antibodies. B and C: Cells transfected by p38a or nontargeted (N.T) siRNA for 96 h (B) or infected with DN-p38a adenoviral constructs at
the indicated MOI (ifu/cell) for 48 h (C) were treated with 50 ng/mL AN for 30 min. ErbB2-pTyr
1248, ErbB3-pTyr
1289, pTyr, ErbB2, and ErbB3
in total cell extract proteins were examined with immunoblot analysis using the indicated antibodies. The levels of ErbB2 and ErbB3 (ErbB2/3) in
C, second panel, were assessed by immunoblot analysis using a mixture of anti-ErbB2 and anti-ErbB3 antibodies (2 mg each). D: Cells were treated
without or with 10 mmol/L SB203580 (SB) for 30 min, before incubation without or with 5 nmol/L TNF, 300 mU/mL SMase, or 50 ng/mL AN for
30 min at 37°C. Total cell extract proteins were analyzed by Western immunoblot analysis using anti-ErbB2-pTyr
1248 antibodies. E: Cells were
treated with 10 mmol/L SB203580 (SB) and 50 ng/mL AN as described above. Immunoprecipitation was performed using p85-PI3K or mixture of
anti-ErbB2 and anti-ErbB3 antibodies and PI3K activity was measured as described in RESEARCH DESIGN AND METHODS (E, upper panels). Cells were
treated without or with 25 mmol/L LY294002 (LY) or 10 mmol/L SB203580 (SB) for 30 min before incubation without or with 50 ng/mL AN for 30 min.
Akt activation was analyzed by immunoblotting with anti-Akt-pSer
473 antibodies (E, lower panel). Each panel in A–E contains a representative
blot of at least three independent experiments. The RBI of a given band in E, upper panels, presents the means of three independent experiments.
Band intensity measurements were performed using ImageJ analysis.
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mote IRS-1 Ser phosphorylation was evaluated in cells
lacking ErbB receptors expression/activity. As depicted in
Fig. 6A, knocking down ErbB1 by siRNA in HepG2 cells
suppressed TNF effect on IRS-1 Ser phosphorylation
without affecting TNF-induced p38MAPK phosphorylation.
Similarly, simultaneous downregulation of ErbB2/ErbB3
expression in Fao cells (by culturing cells at low density
[33]) attenuated AN-stimulated IRS-1 Ser phosphorylation,
despite intact AN-induced p38MAPK activation (Fig. 6B).
Similar ﬁndings were observed in HepG2 cells treated with
PD168393, an ErbB1 Tyr kinase inhibitor, or in Fao cells
treated with the ErbB2 kinase inhibitor AG825 (Supple-
mentary Fig. 5).
Involvement of ROS in stress-induced ErbB receptors
activation leading to insulin resistance. ROS had been
suggested to mediate TNF-induced IRS-1 Ser phosphory-
lation in human hepatoma cells (34). Because exposure to
FIG. 5. p38MAPK involvement in stress-induced ErbB receptors transactivation in HepG2 cells and in C57/BL6 mice. HepG2 cell experiments: A
and B: Cells were transfected with 15 MOI (ifu/cell) of b-gal, WT-p38a, and DN-p38a adenoviral constructs (A) or were treated without or with
10 mmol/L SB203580 for 30 min (B), before incubation without or with 5 nmol/L TNF for 30 min. Level of ErbB1-pTyr
1173, ErbB1-pTyr
1086, ErbB1,
ErbB3-pTyr
1289, ErbB3, and MAPKAPK2-pThr
334 were assessed using Western immunoblot analysis. C: Cells were treated without or with 25 mmol/L
PD98059 (PD), 10 mmol/L SB203580, or 100 nmol/L wortmannin (Wort) for 30 min before incubation without or with 5 nmol/L TNF for 30 min. Akt
activation was analyzed by immunoblotting with anti-Akt-pSer
473 antibodies. Each panel in A–C contains a representative blot of three in-
dependent experiments. The RBI of a given band presents the means of three independent experiments, and intensity measurements were per-
formed using ImageJ analysis. Mice model experiments: D: ErbB1-pTyr
1173 and ErbB1 in the liver of C57 mice infected with b-gal (n = 10) or
WT-p38a (n = 9) adenoviral constructs via tail vein injection were assessed using Western blot analysis. Quantiﬁcation of immunoblots was
performed using ImageJ analysis. The results are expressed as ErbB1-pTyr
1173 relative to ErbB1 and are presented as the means 6 SE. E: Levels of
ErbB1-pTyr1173, ErbB1, ErbB3-pTyr
1289, ErbB3, and a-tubulin in the liver of C57 mice fed with either standard diet (n = 5) or HFD (n = 5) were
assessed using Western blot analysis. Quantiﬁcation of immunoblots was performed using ImageJ analysis. The results are expressed as ErbB1-
pTyr
1173, ErbB1, ErbB3-pTyr
1289, or ErbB3 relative to the loading control (a-tubulin) and are presented as the means 6 SE.
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vation as well as ErbB receptors transactivation in various
cellular models, we aimed at assessing whether the stress-
induced p38MAPK-ErbB pathway leading to IRS-1 Ser
phosphorylation is mediated by ROS. Indeed, TNF and AN
promoted intracellular ROS generation in Fao cells, as
demonstrated by increased oxidation of the redox-sensitive
dye CM-DCF (Fig. 7A). Moreover, similar to our observa-
tions with TNF and AN, exposure of Fao cells to oxidative
stress (treatment with GO in the presence of glucose) in-
duced p38MAPK activation, ErbB2/ErbB3 transactivation,
and IRS-1 Ser phosphorylation (Fig. 7B). ErbB2/ErbB3
transactivation by oxidative stress was supported by en-
hanced ErbB2/ErbB3 Tyr phosphorylation, coupled to in-
creased association with PI3K and Akt activation (Fig. 7C).
ErbB2/ErbB3 Tyr phosphorylation and IRS-1 Ser phos-
phorylation under oxidative stress followed in time course
the activation of p38MAPK (Fig. 7B) and were almost
completely abolished by p38MAPK inhibition (Fig. 7D). To
further study the relevance of stress-induced ROS gener-
ation in p38MAPK-mediated ErbB2/ErbB3 transactivation,
Fao cells were pretreated with different antioxidants be-
fore stress exposure. NAC and GSH, modulators of cellular
thiol levels, and DPI, a general inhibitor of ﬂavoprotein-
containing oxidases (such as NADPH oxidase and nitric
oxide synthase), signiﬁcantly decreased the ability of AN
(Fig. 7E), SMase, and TNF (data not shown) to induce
ErbB2/ErbB3 transactivation, associated with signiﬁcant
inhibition in the activation of both p38MAPK and its up-
stream regulators MKK3/MKK6 (Fig. 7E). Additionally, NAC
signiﬁcantly decreased stress-induced IRS-1 Ser phos-
phorylation (Fig. 7F, upper panels) resulting in complete
restoration of the in vitro interaction of IRS-1 with the IR
(Fig. 7F, lower panel). Unlike stress-induced ErbB2/
ErbB3 transactivation, ErbB2/ErbB3 Tyr phosphorylation,
stimulated by the natural ligand NDF-b1, was unaffected by
NAC, indicating that NAC does not inhibit ErbB2 tyrosine
kinase activity per se (Fig. 7G). Collectively, these ﬁndings
suggest a putative role for stress-induced ROS production in
activation of the p38MAPK-ErbB cascade leading to insulin
resistance.
DISCUSSION
The current study proposes new insight for the pivotal role
of p38MAPK in the induction of insulin resistance; here we
provide evidence that p38MAPK activation is required for
ErbB receptors transactivation by various stresses, which
then signals through a PI3K signaling cascade to promote
insulin-signaling impairment (see suggested model in Fig. 8).
Several lines of evidence support this mechanism. First,
stress stimuli including TNF, SMase, AN, and oxidative
stress promoted p38MAPK activation in several hepatic
cell lines, which paralleled in time course the ErbB
receptors Tyr phosphorylation (ErbB 2/3 in Fao and
ErbB1/3 in HepG2 cells). Second, inhibition of p38MAPK
activity either by a pharmacological inhibitor, by DN-
p38MAPKa, or by its silencing with speciﬁc p38MAPKa
siRNA prevented the stress-induced ErbB receptors Tyr
phosphorylation and their downstream signaling pathways.
Correspondingly, inhibition of p38MAPK activation atten-
uated the stress-induced IRS-1 Ser phosphorylation on
speciﬁc residues, which are known to mediate the stress-
induced downregulation of insulin action (35–38). Indeed,
p38MAPK inhibition improved IRS-1 ability to interact
with IR and partially recovered Tyr phosphorylation of
FIG. 6. The interrelationship between stress-induced ErbB Tyr phosphorylation, p38MAPK activation, and IRS-1 Ser phosphorylation. A:H e p G 2
cells transfected by nontargeted (N.T) or ErbB1 siRNA for 96 h were treated without or with 5 nmol/L TNF for 30 min at 37°C. ErbB1, ErbB1-
pTyr
1086, ErbB1-pTyr
1173, IRS-1-pSer
312, IRS-1-pSer
616, IRS-1-pSer
636, IRS-1, p-p38, and p38 in total cell extract proteins were assessed using
Western blot analysis. B: Fao cells, grown at various cell densities for 48 h, were incubated without or with 50 ng/mL AN for 30 min at 37°C.
Particulate fractions were analyzed by immunoblot analysis using a mixture of anti-ErbB2 and anti-ErbB3 antibodies or anti-pTyr antibody. Cy-
tosolic fractions were analyzed by immunoblot analysis using antibodies against IRS-1-pSer
307, IRS-1-pSer
612, IRS-1-pSer
632, IRS-1, p-p38, p38,
MKK3/6 pSer
189/207, and MKK3. Each panel contains a representative blot of three to ﬁve independent experiments.
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of the suggested model is demonstrated by the beneﬁcial
effects of p38MAPKa attenuation on the improvement of
metabolic derangements observed in an animal model for
insulin resistance.
In support of the suggested mechanism, p38MAPK
phosphorylation was found to be increased in the liver of
ob/ob mice (26,27) and in skeletal muscle and adipocytes
of type 2 diabetic patients (39,40), as well as in adipose tissue
of Zucker obese rats, where treatment with rosiglitazone
decreased its activation accompanied by reduced IRS-1
Ser phosphorylation (41). Furthermore, p38MAPK-dependent
phosphorylation of Ser
307 was reported in rat myotubes
chronically exposed to TNF (19) and inhibition of p38MAPK
under oxidative conditions or treatment with the antioxi-
dant a-lipoic acid restored insulin sensitivity (14,42).
The precise function of p38MAPK or its downstream
effectors in mediating ligand-independent ErbB receptors
FIG. 7. Effects of ROS on stress-induced p38MAPK activation, ErbB2/ErbB3 transactivation, and IRS-1 Ser phosphorylation. A: ROS production in
TNF- and AN-treated Fao cells was measured by the ROS-sensitive ﬂuorescent dye CM-DCF. B: Particulate fraction proteins from Fao cells treated
with 0.1 units/mL GO for the indicated times were analyzed by immunoblotting using anti-pTyr antibodies (upper panel), and the cytosolic fraction
proteins were resolved by SDS-PAGE and then immunoblotted with antibodies as indicated. C: Fao cells were incubated with GO for the indicated
doses for 15 min and with 50 ng/mL AN for 30 min. Proteins from cell lysates were immunoprecipitated by using a mixture of anti-ErbB2 and ErbB3
antibodies, resolved by SDS-PAGE, and immunoblotted with anti-pTyr or anti-p85 antibodies (C, upper panels) or directly resolved by SDS-PAGE
and then immunoblotted with anti-pTyr, anti-Akt-pSer
473, and anti-Akt antibodies (C, lower panels). D: Total extracts, obtained from cells treated
with 10 mmol/L SB203580 (SB) for 30 min before incubation with GO at the indicated doses, were resolved by SDS-PAGE and then immunoblotted
with antibodies as indicated. E: Total proteins obtained from cells treated for 1 h without or with GSH, NAC, and DPI at the indicated doses (upper
panels), or with 10 mmol/L GSH and 0.1 mmol/L DPI (lower panel) before incubation without or with 50 ng/mL AN for 30 min, were analyzed by
immunoblot analysis using antibodies against pTyr, p-p38, and MKK3/6-pSer
189/207. F: Total proteins obtained from cells treated without or with 10
mmol/L NAC before incubation with 50 ng/mL AN or 300 mU/mL SMase as described above were analyzed by immunoblotting using anti-IRS-1-
pSer
612 and anti-IRS-1-pSer
307 antibodies (F, upper panels). Cytosolic proteins obtained from cells treated without or with 10 mmol/L NAC for 1 h,
and without or with AN or SMase, as described above, were bound to immobilized IR. IR-IRS complexes were resolved by SDS-PAGE and
immunoblotted with anti-IRS-1 antibodies (F, lower panel). Each panel in A–F contains a representative blot of at least three independent
experiments. G: Total proteins obtained from cells treated for 1 h without or with 10 mmol/L NAC before incubation with 50 ng/mL NDF-b1 for 15
min were analyzed by immunoblot analysis using antibodies against pTyr.
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mechanism may be suggested by the observation that in
cells exposed to oxidative stress speciﬁc Tyr phosphatases
were neutralized by p38MAPK, leading to sustained Tyr
phosphorylation of ErbB1 (43). Other reports have dem-
onstrated that stress stimuli, including SMase, H2O2, and
heat shock, mediate the activation of ErbB proteins
through nonreceptor Tyr kinases such as Src and Pyk2
(44–46), although the role of p38MAPK in activation of
these kinases is not established. A third potential mecha-
nism was suggested by the observation that, under stress
conditions, p38MAPK mediates metalloprotease activation
and proteolytic processing of pro-HB-EGF ligand pre-
cursors, leading to ErbB1 transactivation (23). Recent
studies demonstrated that stress-induced p38MAPK path-
way mediates ErbB1 phosphorylation on several Ser/Thr
residues located at the carboxy-terminal tail of the re-
ceptor (47); however, the relevance of such an event to
ErbB receptors transactivation is not clear. Further studies
will be necessary to identify the pathways that link
p38MAPK to ErbB receptors transactivation.
Increased ROS levels by TNF had been shown to be an
important trigger for insulin resistance (5). Our ﬁndings of
increased ROS production by stress stimuli, p38MAPK-
ErbB pathway activation by oxidative stress and the ability
of antioxidants to restore insulin sensitivity following ex-
posure to stress stimuli, point to a potential role of ROS
generation in mediating stress-induced p38MAPK-ErbB
receptors activation leading to insulin resistance (Fig. 8).
Such a mechanism is supported by the observation that
TNF induces insulin resistance in hepatic cells through
increased ROS production, which results in sustained ac-
tivation of ASK1 (34), an upstream activator of the MKK3/
MKK6-p38MAPK cascade (48), and the ﬁnding that EGF-
receptor transactivation by TNF is regulated in a redox-
dependent manner (49). In addition, ROS production in
response to TNF had been shown to inactivate MAPK
phosphatases leading to sustained MAPK activation (50).
The possibility that ROS generation, in response to stress
stimuli, may promote IRS-1 Ser phosphorylation through
stimulation of additional signaling pathways cannot be ex-
cluded, since the antioxidant NAC attenuated not only
p38MAPK activation but also JNK activation (results not
shown). Whereas JNK promotes TNF- and AN-induced in-
sulin resistance by direct association with IRS-1 and phos-
phorylation of Ser
307 (15,51), our ﬁndings demonstrate that
p38MAPK regulates IRS-1 Ser phosphorylation indirectly
through ErbB receptors activation of downstream kinases.
Thus stress-induced IRS-1 Ser phosphorylation may be
triggered by multiple pathways activating different IRS-1
kinases (38), which act in concert to impair insulin action
(Fig. 8). Further studies will be required to establish the
potential linkage between ROS generation and the
p38MAPK-ErbB cascade in insulin resistance induction.
In conclusion, the current study suggests a novel mech-
anism underlying the development of hepatic insulin re-
sistance under cellular stress conditions. In response to
different stress stimuli, p38MAPK activation initiates ErbB
receptors signaling, leading to Ser phosphorylation of IRS
proteins and impaired cellular response to insulin. This may
provide a mechanism which enables diversion of cell ma-
chinery from controlled nutrient transport and anabolism to
that of survival, growth, and repair. Further studies will be
required to assess the relevance of the proposed mecha-
nism in other insulin target tissues.
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